Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG for Heart Failure Prevention After MI
NCT00430885Phase 3Completed
- Sponsor
- Oslo University Hospital
- Start
- Feb 2007
- Primary completion
- May 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of intravenous immunoglobulin G in heart failure (HF), sponsored by Oslo University Hospital. Started Feb 2007; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00430885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430885.